ARTICLE | Company News
Genstruct, Pfizer deal
November 15, 2004 8:00 AM UTC
Genstruct will use its Molecular Epistemics technology to identify mechanisms of action and toxicity of PFE products and develop biomarkers to improve leads and optimize clinical trial design. Molecul...